- Home
- OZ vs INBX Comparison
OZ vs INBX Comparison
Compare OZ & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- INBX
- Stock Information
- Founded
- OZ 2020
- INBX 2010
- Country
- OZ United States
- INBX United States
- Employees
- OZ N/A
- INBX N/A
- Industry
- OZ
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- OZ
- INBX Health Care
- Exchange
- OZ Nasdaq
- INBX Nasdaq
- Market Cap
- OZ 239.8M
- INBX 178.5M
- IPO Year
- OZ N/A
- INBX 2020
- Fundamental
- Price
- OZ $64.39
- INBX $18.35
- Analyst Decision
- OZ
- INBX Hold
- Analyst Count
- OZ 0
- INBX 1
- Target Price
- OZ N/A
- INBX N/A
- AVG Volume (30 Days)
- OZ 1.7K
- INBX 95.4K
- Earning Date
- OZ 01-01-0001
- INBX 08-12-2025
- Dividend Yield
- OZ N/A
- INBX N/A
- EPS Growth
- OZ N/A
- INBX N/A
- EPS
- OZ N/A
- INBX 111.58
- Revenue
- OZ $4,077,000.00
- INBX $200,000.00
- Revenue This Year
- OZ N/A
- INBX N/A
- Revenue Next Year
- OZ N/A
- INBX N/A
- P/E Ratio
- OZ N/A
- INBX $0.16
- Revenue Growth
- OZ 94.70
- INBX N/A
- 52 Week Low
- OZ $56.77
- INBX $10.80
- 52 Week High
- OZ $82.89
- INBX $18.42
- Technical
- Relative Strength Index (RSI)
- OZ 45.73
- INBX 76.88
- Support Level
- OZ $65.58
- INBX $13.97
- Resistance Level
- OZ $67.02
- INBX $15.25
- Average True Range (ATR)
- OZ 0.62
- INBX 0.88
- MACD
- OZ -0.10
- INBX 0.23
- Stochastic Oscillator
- OZ 2.00
- INBX 97.99
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.